Intratumoral heterogeneity of intrahepatic cholangiocarcinoma

No personalized therapy regimens could demonstrate a benefit in survival of intrahepatic cholangiocarcinoma (iCCA). Since genetic heterogeneity might influence single biopsy based targeted therapy or the outcome of clinical trials, aim of the present study was to investigate intratumoral heterogenei...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Walter, Dirk, Döring, Claudia, Feldhahn, Magdalena, Battke, Florian, Hartmann, Sylvia, Winkelmann, Ria, Schneider, Markus, Bankov, Katrin, Schnitzbauer, Andreas, Zeuzem, Stefan, Hansmann, Martin Leo, Peveling-Oberhag, Jan
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362457/
https://ncbi.nlm.nih.gov/pubmed/28146430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14844
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars